AXOVANT SCIENCES LTD's ticker is AXGTXXXX and the CUSIP is G0750W104. A total of 128 filers reported holding AXOVANT SCIENCES LTD in Q3 2017. The put-call ratio across all filers is 1.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $13,000 | -71.7% | 12,620 | -33.1% | 0.00% | – |
| Q3 2018 | $46,000 | -81.1% | 18,853 | -89.7% | 0.00% | – |
| Q1 2018 | $244,000 | +559.5% | 183,223 | +2519.0% | 0.00% | – |
| Q4 2017 | $37,000 | -99.0% | 6,996 | -98.7% | 0.00% | -100.0% |
| Q3 2017 | $3,553,000 | -83.4% | 526,283 | -43.0% | 0.00% | -80.0% |
| Q2 2017 | $21,419,000 | +193.2% | 923,649 | +88.9% | 0.01% | +150.0% |
| Q1 2017 | $7,306,000 | +25.2% | 489,024 | +4.1% | 0.00% | +100.0% |
| Q4 2016 | $5,836,000 | -13.3% | 469,895 | -2.3% | 0.00% | -50.0% |
| Q3 2016 | $6,730,000 | -40.1% | 480,722 | -45.0% | 0.00% | -33.3% |
| Q2 2016 | $11,231,000 | +9.4% | 874,644 | -2.2% | 0.00% | 0.0% |
| Q1 2016 | $10,266,000 | -36.9% | 894,297 | -0.8% | 0.00% | -25.0% |
| Q4 2015 | $16,260,000 | +130.3% | 901,838 | +65.0% | 0.00% | +100.0% |
| Q3 2015 | $7,059,000 | -17.3% | 546,436 | +30.4% | 0.00% | 0.0% |
| Q2 2015 | $8,537,000 | – | 418,916 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,000,000 | $57,400,000 | 7.34% |
| VHCP Management II, LLC | 429,590 | $4,932,000 | 3.24% |
| VHCP Management, LLC | 184,110 | $2,114,000 | 1.84% |
| Visium Asset Management, LP | 4,192,769 | $48,132,000 | 0.82% |
| Perceptive Advisors | 485,000 | $5,568,000 | 0.49% |
| Opus Point Partners Management, LLC | 26,416 | $303,000 | 0.23% |
| Virtus ETF Advisers LLC | 12,579 | $144,000 | 0.20% |
| BOURGEON CAPITAL MANAGEMENT LLC | 20,700 | $238,000 | 0.16% |
| AMERICAN FINANCIAL GROUP INC | 172,395 | $1,980,000 | 0.15% |
| NJ State Employees Deferred Compensation Plan | 51,000 | $640,000 | 0.14% |